PAPER Nag S, Sarkar B, Bandyopadhyay A, Sahoo B, Sreenivasan VK, Kombrabail M, Muralidharan C, Maiti S
SEARCH RESULTS
329938 RESULTS
PAPER Damulin IV, Stepkina DA, Lokshina AB
[Neuromidin in mixed vascular and Alzheimer's dementia].
Zh Nevrol Psikhiatr Im S S Korsakova. 2011;111(2):40-3. PubMed: 21350422PAPER Mohamed A, Posse de Chaves E
Aβ internalization by neurons and glia.
Int J Alzheimers Dis. 2011;2011:127984. PubMed: 21350608PAPER Martin A, De Vivo G, Gentile V
Possible role of the transglutaminases in the pathogenesis of Alzheimer's disease and other neurodegenerative diseases.
Int J Alzheimers Dis. 2011;2011:865432. PubMed: 21350675PAPER Kozin SA, Mezentsev YV, Kulikova AA, Indeykina MI, Golovin AV, Ivanov AS, Tsvetkov PO, Makarov AA
Zinc-induced dimerization of the amyloid-β metal-binding domain 1-16 is mediated by residues 11-14.
Mol Biosyst. 2011 Apr;7(4):1053-5. PubMed: 21350790PAPER Royall DR, Palmer R, Chiodo LK, Polk MJ
Depressive symptoms predict longitudinal change in executive control but not memory.
Int J Geriatr Psychiatry. 2012 Jan;27(1):89-96. PubMed: 21351296PAPER Mohamed A, Cortez L, de Chaves EP
Aggregation state and neurotoxic properties of alzheimer β-amyloid peptide.
Curr Protein Pept Sci. 2011 May 1;12(3):235-57. PubMed: 21348837PAPER Pritchard SM, Dolan PJ, Vitkus A, Johnson GV
The toxicity of tau in Alzheimer disease: turnover, targets and potential therapeutics.
J Cell Mol Med. 2011 Aug;15(8):1621-35. PubMed: 21348938PAPER Bonda DJ, Lee HG, Camins A, Pallàs M, Casadesus G, Smith MA, Zhu X
The sirtuin pathway in ageing and Alzheimer disease: mechanistic and therapeutic considerations.
Lancet Neurol. 2011 Mar;10(3):275-9. PubMed: 21349442PAPER Texidó L, Martín-Satué M, Alberdi E, Solsona C, Matute C
Amyloid β peptide oligomers directly activate NMDA receptors.
Cell Calcium. 2011 Mar;49(3):184-90. PubMed: 21349580PAPER Liu Y, Lee SY, Neely E, Nandar W, Moyo M, Simmons Z, Connor JR
Mutant HFE H63D protein is associated with prolonged endoplasmic reticulum stress and increased neuronal vulnerability.
J Biol Chem. 2011 Apr 15;286(15):13161-70. PubMed: 21349849PAPER Martín-Moreno AM, Reigada D, Ramírez BG, Mechoulam R, Innamorato N, Cuadrado A, De Ceballos ML
Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's disease.
Mol Pharmacol. 2011 Jun;79(6):964-73. PubMed: 21350020PAPER Vishal S, Sourabh A, Harkirat S